Angel Qin
Oncology | Internal Medicine
7500 Challis Rd
Entrance1, Level 1
Brighton, MI 48116
Entrance1, Level 1
Brighton, MI 48116
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Plain language summary of subcutaneous vs IV amivantamab plus lazertinib in EGFR-altered non-small-cell lung cancer.
Journal: Future oncology (London, England)
Published: August 24, 2026
NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 11, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 03, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 03, 2026
Brief Report: Real-World Outcomes of Lurbinectedin in Veterans With Small Cell Lung Cancer.
Journal: Clinical lung cancer
Published: November 30, 2025
An evolving landscape: predictive and therapeutic biomarkers in advanced non-small cell lung cancer.
An evolving landscape: predictive and therapeutic biomarkers in advanced non-small cell lung cancer.
Journal: Frontiers in oncology
Published: November 19, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2025.1.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 17, 2025
Radiotherapy for Unresectable Locally Advanced NSCLC: A Practical Multidisciplinary Approach to Challenging Scenarios From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 09, 2025
Pembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC).
Journal: Clinical lung cancer
Published: June 11, 2025
ACR Appropriateness Criteria® Lung Cancer-Surveillance After Therapy.
Journal: Journal of the American College of Radiology : JACR
Published: February 20, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 12, 2024
Antigen-independent single-cell circulating tumor cell detection using deep-learning-assisted biolasers.
Journal: Biosensors & bioelectronics
Published: October 25, 2024
Last Updated: 09/26/2026